Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $749.2750 (-2.61%) ($748.0750 - $769.9200) on Wed. Feb. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.7% (three month average) | RSI | 64 | Latest Price | $749.2750(-2.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 2.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(43%) DIA(32%) VYM(30%) SPLV(28%) | Factors Impacting REGN price | REGN will decline at least -0.85% in a week (0% probabilities). VIXM(-12%) VXX(-8%) TBT(-3%) UUP(-2%) ACES(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.85% (StdDev 1.7%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $766.48(-2.24%) | 10 Day Moving Average | $758.2(-1.18%) | 20 Day Moving Average | $741.85(1%) | To recent high | -4.5% | To recent low | 10.1% | Market Cap | $79.445b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |